Hyphens Pharma Grants License for Cerapro® MED Skin Barrier Cream Across Six European Countries Hyphens Pharma has licensed its Cerapro® MED Skin Barrier Cream to Louis Widmer for distribution in six European countries, enhancing treatment options for atopic dermatitis.

Hyphens Pharma Grants License for Cerapro® MED Skin Barrier Cream Across Six European Countries #Singapore #Louis_Widmer #Hyphens_Pharma #Cerapro_MED

Hyphens Pharma Secures License for Cerapro® MED Cream Across Six European Nations Hyphens Pharma announces the licensing of its innovative cream, Cerapro® MED, for markets in six European countries. This product targets atopic dermatitis.

Hyphens Pharma Secures License for Cerapro® MED Cream Across Six European Nations #Singapore #Louis_Widmer #Hyphens_Pharma #Cerapro_MED